We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TD icon
2226
Toronto Dominion Bank
TD
$198B
$770K ﹤0.01%
8,254
-6,934
-46% -$659K
INBX icon
2227
Inhibrx
INBX
$1.21B
$769K ﹤0.01%
11,433
-2
-0% -$148
CMCL icon
2228
Caledonia Mining Corp
CMCL
$365M
$764K ﹤0.01%
33,834
+223
+0.7% +$6.22K
PGEN icon
2229
Precigen
PGEN
$1.93B
$764K ﹤0.01%
197,407
+133
+0.1% +$546
CCBG icon
2230
Capital City Bank Group
CCBG
$890M
$763K ﹤0.01%
17,557
-2,567
-13% -$110K
SMBC icon
2231
Southern Missouri Bancorp
SMBC
$854M
$762K ﹤0.01%
11,910
-197
-2% -$12.3K
GOOD
2232
Gladstone Commercial Corp
GOOD
$627M
$760K ﹤0.01%
66,453
+56
+0.1% +$657
ETON icon
2233
Eton Pharmaceutcials
ETON
$1.16B
$758K ﹤0.01%
30,726
+290
+1% +$5.07K
ESPR
2234
DELISTED
Esperion Therapeutics
ESPR
$757K ﹤0.01%
276,401
+6,663
+2% +$21.1K
TFSL icon
2235
TFS Financial
TFSL
$5.07B
$755K ﹤0.01%
53,764
+1,230
+2% +$17.4K
RGR icon
2236
Sturm, Ruger & Co
RGR
$620M
$753K ﹤0.01%
18,775
-1,424
-7% -$54.1K
TRTX
2237
TPG RE Finance Trust
TRTX
$662M
$751K ﹤0.01%
96,221
-3,744
-4% -$32.2K
STM icon
2238
STMicroelectronics
STM
$47.7B
$751K ﹤0.01%
21,748
+847
+4% +$26.5K
TK icon
2239
Teekay
TK
$974M
$750K ﹤0.01%
61,423
-42,888
-41% -$473K
EDP
2240
DELISTED
EDP-ELECT DE PORTUGAL S A (REPTG 10 ORD)
EDP
$750K ﹤0.01%
14,239
+51
+0.4% +$2.69K
KE
2241
Kimball Electronics
KE
$598M
$746K ﹤0.01%
31,511
-640
-2% -$16.9K
IVR icon
2242
Invesco Mortgage Capital
IVR
$762M
$745K ﹤0.01%
92,148
+3,203
+4% +$27.3K
UTZ icon
2243
Utz Brands
UTZ
$1.25B
$739K ﹤0.01%
93,363
-1,053
-1% -$9.78K
MCHB
2244
Mechanics Bancorp
MCHB
$3.46B
$738K ﹤0.01%
50,021
+2,762
+6% +$40.9K
CLVT icon
2245
Clarivate
CLVT
$1.36B
$736K ﹤0.01%
290,793
-3,826
-1% -$9.79K
SION
2246
Sionna Therapeutics
SION
$2.05B
$734K ﹤0.01%
18,308
+614
+3% +$23.4K
CTLP
2247
DELISTED
Cantaloupe
CTLP
$732K ﹤0.01%
67,747
-1,287
-2% -$13.6K
JANX icon
2248
Janux Therapeutics
JANX
$950M
$732K ﹤0.01%
52,637
+276
+0.5% +$3.79K
ASC icon
2249
Ardmore Shipping
ASC
$669M
$730K ﹤0.01%
47,849
-3,029
-6% -$41.6K
FSBC icon
2250
Five Star Bancorp
FSBC
$1.01B
$729K ﹤0.01%
19,340
-42
-0.2% -$1.61K

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.